2927 · AFC-HD AMS Life Science Co.,Ltd. · Financials
Market Cap
12.43B JPY
Shares
14.66M
Volume · Nov 13
13.8K
Avg daily vol (3M)
27.36K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
32.66B
+8.2%
FY2025
Net Income
1.45B
+15.7%
FY2025
Gross Margin
34.49%
-0.3pp
FY2025
Operating Margin
7.38%
+1pp
FY2025
Operating Cash Flow
1.79B
+16%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| JPY | 32.66B | 30.19B | 25.58B | 23B | 22.37B |
| JPY | 21.39B | 19.69B | 16.26B | 14.42B | 15.5B |
| JPY | 11.26B | 10.49B | 9.32B | 8.58B | 6.87B |
| JPY | 2.41B | 1.92B | 1.64B | 1.01B | 2.25B |
| JPY | 2.2B | 1.91B | 1.55B | 1.24B | 2.16B |
| JPY | 732.2M | 665.4M | 439.36M | 497.92M | 662.36M |
| JPY | 1.45B | 1.25B | 1.1B | 735.35M | 1.5B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: 1.97B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.